Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes.
Cruz-López EO, Ren L, Uijl E, Clahsen-van Groningen MC, van Veghel R, Garrelds IM, Domenig O, Poglitsch M, Zlatev I, Rooney T, Kasper A, Nioi P, Foster D, Danser AHJ.
Cruz-López EO, et al.
Br J Pharmacol. 2023 Jan;180(1):80-93. doi: 10.1111/bph.15955. Epub 2022 Oct 2.
Br J Pharmacol. 2023.
PMID: 36106615
Free PMC article.